Insmed Inc. Stock
Price
Target price
€24.00
€24.00
1.690%
0.4
1.690%
€44.01
06.05.24 / Stuttgart Stock Exchange
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insmed Inc. Stock
Insmed Inc. gained 1.690% today.
We see a rather positive sentiment for Insmed Inc. with 13 Buy predictions and 1 Sell predictions.
With a target price of 44 € there is a hugely positive potential of 83.33% for Insmed Inc. compared to the current price of 24.0 €.
So far the community has only identified positive things for Insmed Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insmed Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 1.690% | 3.448% | -4.762% | 36.364% | -16.084% | -7.692% | -14.576% |
| Evolus Inc | -0.810% | 14.019% | 1.667% | 60.526% | 34.807% | 75.540% | - |
| Ardelyx Inc. | -1.640% | 40.927% | 22.899% | 104.125% | 47.266% | 54.764% | - |
| Salarius Pharmaceuticals Inc. | -6.170% | 0.472% | -0.930% | -70.417% | -23.243% | -98.346% | -99.993% |
Comments
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat
